{"id":"W6967308790","doi":"10.5061/dryad.4hk2039","title":"Data from: Randomized phase 2 study of FcRn antagonist efgartigimod in generalized myasthenia gravis","year":2019,"lang":"en","type":"dataset","venue":"Data Archiving and Networked Services (DANS)","topic":"","field":"","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"University Health Network","funders":"","keywords":"Myasthenia gravis; Adverse effect; Placebo; Autoantibody; Antibody; Clinical endpoint; Autoimmune disease; Immunoglobulin G","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002763612,0.001563448,0.003235949,0.00034987,0.0005506809,0.0008831443,0.0008547474,0.001685981,0.0150735],"category_scores_gemma":[0.002263519,0.0005873059,0.001418742,0.0003948094,0.0007156497,0.0008769342,0.0003204645,0.001835767,0.00183562],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005406378,"about_ca_system_score_gemma":0.00155616,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000693938,"about_ca_topic_score_gemma":0.001764147,"domain_scores_codex":[0.9989084,0.0006780039,0.00007746544,0.0001144071,0.0001148321,0.0001069252],"domain_scores_gemma":[0.9988906,0.0003402056,0.0002678707,0.000105743,0.0001109004,0.0002846782],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"not_applicable","study_design_scores_codex":[0.9599764,0.00417191,0.001030469,0.001306151,0.0017795,0.0001072214,0.00003571202,0.0004436589,0.005295101,0.0001148388,0.003617835,0.02212123],"study_design_scores_gemma":[0.971298,0.02386417,0.002266914,0.00003884908,0.0004682223,0.00004810025,0.000006879324,0.0001179855,0.0003110279,0.00005495401,0.001516107,0.000008779292],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"dataset","genre_scores_codex":[0.9148463,0.01730681,0.002659963,0.002653859,0.001176186,0.0309287,0.01997508,0.0005434484,0.009909672],"genre_scores_gemma":[0.9343644,0.007418269,0.00361873,0.004938532,0.0008040789,0.0281087,0.01262465,0.00008525344,0.008037275],"genre_candidate":"dataset","genre_consensus":null,"teacher_disagreement_score":0.0150735,"threshold_uncertainty_score":0.05042589,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0558231961402875,"score_gpt":0.3419614165960355,"score_spread":0.2861382204557479,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}